Tag
zts
2 articles

Zoetis Rated Strong Sell Ahead of Earnings Miss
ZTS slides 2.22% to $71.40 as analysts project double-digit EPS decline and assign Zacks Rank #5; stock trades at 11.77x forward earnings.

Zoetis FDA Delay Is a Buying Opportunity, Not a Verdict
ZTS fell 8 percent after the FDA requested more data on its canine osteoarthritis vaccine, but the selloff overstates the damage to a dominant franchise